Breathe Tech. eyes ventilator market
FREMONT, Calif. - Breathe Technologies, a manufacturer of medical devices to treat COPD, cystic fibrosis and influenza, closed last week on $15 million in its second round of venture funding. The investment was led by Kleiner Perkins Caufield & Byers. Breathe is developing "a unique family of compact, ultra-lightweight, ambulatory respiratory ventilator systems for the hospital, homecare and pandemic markets," according to a release. The company believes it could enhance or replace $2 billion in annual worldwide sales of conventional respiratory systems.